← Open Payments lookup

FRANKLIN DEDOMINICIS: Open Payments

NPI 1871031492 · HAMDEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,824 in 136 payments from 18 companies in 2025. Trend: 2023 $2,031 · 2024 $2,117 · 2025 $2,824

Food & beverage: $2,824
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP28$693
ABBVIE INC.37$553
Otsuka America Pharmaceutical, Inc.18$437
GlaxoSmithKline, LLC.16$299
Novo Nordisk Inc7$183
Lundbeck LLC6$134
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$112
Axsome Therapeutics, Inc.3$89
Amgen Inc.3$71
Exact Sciences Corporation2$42

Products named: REXULTI, VRAYLAR, BREZTRI, FARXIGA, TRELEGY ELLIPTA, NUCALA, XIFAXAN, Auvelity.

Industry payments across CT — which companies pay providers there.